Renal medullary carcinoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Renal medullary carcinoma
Synonyms	RMC
Pronounce	N/A
Specialty	N/A
Symptoms	Hematuria, flank pain, weight loss, fever
Complications	Metastasis, renal failure
Onset	Typically in adolescence or young adulthood
Duration	Progressive
Types
Causes	Associated with sickle cell trait
Risks	Sickle cell trait, African descent
Diagnosis	Histopathology, imaging studies
Differential diagnosis	Renal cell carcinoma, urothelial carcinoma
Prevention
Treatment	Chemotherapy, surgery
Medication
Prognosis	Poor
Frequency	Rare
Deaths	N/A

Renal medullary carcinoma is a rare type of kidney cancer that primarily affects young adults and is associated with sickle cell trait. This cancer is aggressive and is often diagnosed at an advanced stage.

Symptoms

The symptoms of renal medullary carcinoma can vary, but may include:

• Blood in the urine (hematuria)
• Abdominal pain
• Weight loss
• Anemia

Causes

Renal medullary carcinoma is associated with sickle cell trait. This is a condition in which a person has one abnormal hemoglobin gene and one normal hemoglobin gene. It is not the same as sickle cell disease, which is a serious disorder in which the body makes sickle-shaped red blood cells.

Diagnosis

Diagnosis of renal medullary carcinoma can be challenging due to its rarity. It is often diagnosed through a combination of imaging tests, such as CT scans or MRIs, and a biopsy of the tumor.

Treatment

Treatment for renal medullary carcinoma typically involves a combination of surgery, chemotherapy, and radiation therapy. However, due to the aggressive nature of this cancer, it is often diagnosed at an advanced stage when treatment is less likely to be successful.

Prognosis

The prognosis for renal medullary carcinoma is generally poor, with a median survival time of less than a year. However, survival can vary depending on factors such as the stage of the cancer at diagnosis and the patient's overall health.

See also

• Kidney cancer
• Sickle cell trait
• Hemoglobin

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia